Tim Vigers

2.1k total citations
60 papers, 828 citations indexed

About

Tim Vigers is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tim Vigers has authored 60 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tim Vigers's work include Diabetes Management and Research (29 papers), Pancreatic function and diabetes (18 papers) and Cystic Fibrosis Research Advances (15 papers). Tim Vigers is often cited by papers focused on Diabetes Management and Research (29 papers), Pancreatic function and diabetes (18 papers) and Cystic Fibrosis Research Advances (15 papers). Tim Vigers collaborates with scholars based in United States, Netherlands and Australia. Tim Vigers's co-authors include Laura Pyle, Gregory P. Forlenza, Christine L. Chan, Laurel H. Messer, Kimberly A. Driscoll, Cari Berget, Kristen J. Nadeau, Philip Zeitler, R. Paul Wadwa and Janet K. Snell‐Bergeon and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Tim Vigers

51 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Vigers United States 15 573 390 336 187 51 60 828
Claudia Piona Italy 16 357 0.6× 243 0.6× 212 0.6× 46 0.2× 22 0.4× 59 569
A. Riis Denmark 9 458 0.8× 274 0.7× 133 0.4× 71 0.4× 101 2.0× 10 804
Омар Мустафа United Kingdom 15 283 0.5× 165 0.4× 78 0.2× 54 0.3× 64 1.3× 34 450
Holger Haberland Germany 15 568 1.0× 449 1.2× 410 1.2× 13 0.1× 71 1.4× 27 779
Juan F. Cano-Pérez Spain 7 271 0.5× 59 0.2× 111 0.3× 77 0.4× 56 1.1× 11 429
Marco Marigliano Italy 19 505 0.9× 403 1.0× 388 1.2× 15 0.1× 65 1.3× 66 864
Hanna Dis Margeirsdottir Norway 14 509 0.9× 154 0.4× 222 0.7× 19 0.1× 36 0.7× 25 763
Helen Mosnier-Pudar France 10 328 0.6× 176 0.5× 91 0.3× 49 0.3× 35 0.7× 31 479
Oliver Harzer Germany 10 219 0.4× 116 0.3× 73 0.2× 83 0.4× 47 0.9× 17 515
Yoel Toledano Israel 15 330 0.6× 130 0.3× 67 0.2× 28 0.1× 76 1.5× 53 646

Countries citing papers authored by Tim Vigers

Since Specialization
Citations

This map shows the geographic impact of Tim Vigers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Vigers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Vigers more than expected).

Fields of papers citing papers by Tim Vigers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Vigers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Vigers. The network helps show where Tim Vigers may publish in the future.

Co-authorship network of co-authors of Tim Vigers

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Vigers. A scholar is included among the top collaborators of Tim Vigers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Vigers. Tim Vigers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goodrich, Jesse A., Meda E. Pavkov, Daniël H. van Raalte, et al.. (2024). Glycoprotein Acetyls Associate With Intraglomerular Hemodynamic Dysfunction, Albuminuria, Central Adiposity, and Insulin Resistance in Youth With Type 1 Diabetes. Canadian Journal of Diabetes. 48(4). 244–249.e1. 1 indexed citations
3.
Simon, Stacey L., Janet K. Snell‐Bergeon, Michal Schäfer, et al.. (2024). Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR‐T1D study. Diabetes Obesity and Metabolism. 26(7). 2662–2672. 2 indexed citations
4.
Trojanowski, Paige J., G. Todd Alonso, Shideh Majidi, et al.. (2023). A randomized controlled clinical trial to improve health outcomes in youth with type 1 diabetes: Study design and baseline characteristics. Contemporary Clinical Trials. 131. 107270–107270. 3 indexed citations
5.
Ode, Katie Larson, et al.. (2023). A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers. Frontiers in Endocrinology. 14. 1183288–1183288. 5 indexed citations
7.
Carry, Patrick M., Tim Vigers, Lauren A. Vanderlinden, et al.. (2023). Propensity scores as a novel method to guide sample allocation and minimize batch effects during the design of high throughput experiments. BMC Bioinformatics. 24(1). 86–86. 3 indexed citations
8.
Sen, Taha, Wenjun Ju, Viji Nair, et al.. (2023). Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes. Kidney International. 104(4). 828–839. 16 indexed citations
9.
Barker, Alex J., et al.. (2022). Estimation of glomerular filtration rate in a pediatric population using non-contrast kidney phase contrast magnetic resonance imaging. Pediatric Nephrology. 38(8). 2877–2881. 3 indexed citations
10.
Looker, Helen C., Laura Pyle, Tim Vigers, et al.. (2022). Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes. Diabetes Care. 45(2). 436–443. 10 indexed citations
11.
Vigers, Tim, et al.. (2022). Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes Technology & Therapeutics. 25(2). 116–121. 1 indexed citations
12.
Vigers, Tim, Patrick M. Carry, Lauren A. Vanderlinden, et al.. (2021). Epigenome-Wide Association Study of Infant Feeding and DNA Methylation in Infancy and Childhood in a Population at Increased Risk for Type 1 Diabetes. Nutrients. 13(11). 4057–4057. 3 indexed citations
13.
Forlenza, Gregory P., Tim Vigers, Cari Berget, et al.. (2021). Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technology & Therapeutics. 24(3). 157–166. 9 indexed citations
15.
Messer, Laurel H., Cari Berget, Laura Pyle, et al.. (2021). Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technology & Therapeutics. 23(12). 837–843. 52 indexed citations
16.
Vigers, Tim, Suzanne Bennett Johnson, Laura Pyle, et al.. (2021). Pump It Up! A randomized clinical trial to optimize insulin pump self-management behaviors in adolescents with type 1 diabetes. Contemporary Clinical Trials. 102. 106279–106279. 7 indexed citations
17.
Vigers, Tim, et al.. (2020). Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology. Journal of Diabetes Science and Technology. 15(3). 630–635. 19 indexed citations
18.
Sopfe, Jenna, Tim Vigers, Laura Pyle, Roger Giller, & Gregory P. Forlenza. (2020). Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Diabetes Technology & Therapeutics. 22(10). 727–733. 10 indexed citations
19.
Shah, Viral N., Prakriti Joshee, Rachel Sippl, et al.. (2019). Type 1 diabetes onset at young age is associated with compromised bone quality. Bone. 123. 260–264. 29 indexed citations
20.
Chan, Christine L., Tim Vigers, Laura Pyle, et al.. (2018). Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline. Journal of Cystic Fibrosis. 17(6). 783–790. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026